Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta… - Expert review of anti …, 2013 - Taylor & Francis
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta… - Expert Review of Anti …, 2013 - search.proquest.com
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Combination therapy for carbapenem-resistant Gram-negative bacteria.
AP Zavascki, JB Bulitta… - Expert Review of Anti …, 2013 - europepmc.org
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta… - Expert Review of Anti …, 2013 - research.monash.edu
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
[PDF][PDF] Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta, B Cornelia - Expert Rev. Anti Infect. Ther, 2013 - ccihadm.med.br
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta… - Expert review of anti …, 2013 - pubmed.ncbi.nlm.nih.gov
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Combination therapy for carbapenem-resistant Gram-negative bacteria.
AP Zavascki, JB Bulitta, CB Landersdorfer - 2013 - cabidigitallibrary.org
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …